OR | 95% CI | |
---|---|---|
DAS28 remission | ||
Group 2 versus group 1* | 11.35 | 5.82 to 22.14 |
SDAI remission | ||
Group 2 versus group 1* | 7.52 | 3.71 to 15.25 |
Baseline ESR (mm/h) | 2.17 | 1.01 to 4.67 |
ACR/EULAR remission | ||
Group 2 versus group 1* | 9.17 | 4.15 to 20.97 |
Baseline ESR (mm/h) | 1.96 | 1.03 to 3.74 |
*Group 1, patients with persistent moderate disease activity at 6- and 12-month visits; group 2, patients with sustained DAS28 remission at 6- and 12-month visits.
ACR/EULAR, American College of Rheumatology/European League Against Rheumatism; DAS28, Disease Activity Score in 28 joints; ESR, erythrocyte sedimentation rate; SDAI, Simplified Disease Activity Index.